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ORIGINAL RESEARCH
Satisfaction Survey for a Medication 
Management Program: Satisfaction 
Guaranteed?
Priti Flanagan, Suman Kainth, and Lisa Nissen
ABSTRACT
Background: Providing clinical pharmacy services to patients in their
homes after discharge from hospital has been reported to reduce health
care costs and improve outcomes. The Medication Management 
Program of the Fraser Health Authority involves pharmacists making
home visits to provide clinical pharmacy services to elderly patients who
have recently been discharged from hospital and others considered to be
at high risk for adverse drug events. Although clinical and economic out-
comes of this program have been evaluated, humanistic outcomes such
as satisfaction have not been assessed. Moreover, very little evaluation of
patient satisfaction with home pharmacy services has been reported in
the literature.
Objective: To evaluate patient satisfaction with the Medication Man-
agement Program.
Methods: A telephone survey instrument, consisting of 7 Likert-scale
items and 2 open-ended questions, was developed and administered to
patients who received a home pharmacist visit between September 1 and
November 23, 2011. In addition to the survey responses, demographic
and clinical data for both respondents and nonrespondents were collected.
Results: Of the 175 patients invited to participate in the survey, 103
(58.9%) agreed to participate. The majority of respondents agreed or
strongly agreed with all of the survey items, indicating satisfaction with
the program. For example, 97 (94%) agreed or strongly agreed that they
would recommend the pharmacist home visit program continue to be
available, and all 103 (100%) agreed or strongly agreed that they were
satisfied with the pharmacist home visit. Respondents provided some
suggestions for program improvement.
Conclusions: The survey findings demonstrate that patients were 
satisfied with the home clinical pharmacy services offered through the
Fraser Health Medication Management Program.
Keywords: pharmacy, satisfaction, home care
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RÉSUMÉ
Contexte : La prestation de services de pharmacie clinique aux patients
à domicile après leur congé de l’hôpital réduirait les coûts de soins de
santé et améliorerait les résultats selon des rapports. Dans le cadre du
Programme de gestion des médicaments de la Fraser Health Authority,
des pharmaciens se rendent au domicile de patients âgés ayant récem-
ment obtenu leur congé de l’hôpital et d’autres patients considérés
comme à risque élevé d’événements indésirables liés aux médicaments
pour leur fournir des services de pharmacie clinique. Bien qu’on ait
évalué les incidences cliniques et économiques de tels services, l’aspect
humain, comme la satisfaction, n’a pas fait l’objet d’évaluations. En
outre, on trouve très peu de données dans la littérature sur l’évaluation
de la satisfaction des patients à l’égard des services de pharmacie 
clinique à domicile.
Objectif : Évaluer la satisfaction des patients à l’égard du Programme
de gestion des médicaments.
Méthodes : Un questionnaire à sept énoncés évalués sur une échelle de
Likert et à deux questions ouvertes a été développé et utilisé pour
réaliser un sondage téléphonique auprès des patients qui avaient reçu
la visite à leur domicile d’un pharmacien entre le premier septembre et
le 23 novembre 2011. En plus des réponses au sondage, des données
démographiques et cliniques ont été collectées à propos des répondants
et des non-répondants.
Résultats : Des 175 patients invités à participer au sondage, 103 (58,9
%) ont accepté. La majorité des répondants étaient d’accord ou tout à
fait d’accord avec tous les énoncés du sondage, indiquant ainsi leur 
satisfaction à l’égard du programme. Par exemple, 97 (94 %) étaient
d’accord ou tout à fait d’accord pour recommander que l’on continue
d’offrir le programme de pharmacie clinique à domicile et la totalité
des 103 (100 %) participants étaient d’accord ou tout à fait d’accord
pour dire qu’ils étaient satisfaits de la visite du pharmacien à domicile.
Les répondants ont formulé quelques suggestions pour améliorer le
programme.
Conclusions : Les résultats du sondage indiquent que les patients
étaient satisfaits des services de pharmacie clinique à domicile offerts
dans le cadre du Programme de gestion des médicaments de la Fraser
Health Authority.
Mots clés : pharmacie, satisfaction, soins à domicile
[Traduction par l’éditeur]
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INTRODUCTION
Providing clinical pharmacy services to patients in theirhomes after discharge from hospital has been reported to
reduce readmissions to hospital, visits to the emergency depart-
ment, and days in hospital during subsequent stays, as well as
improving clinical outcomes.1-4 On the basis of literature
demonstrating the benefits of such service, the Medication
Management Program (MMP) was established in 2005 in the
Fraser Health Authority, 1 of 6 health authorities in the
province of British Columbia, Canada. The MMP is available
in the following Fraser Health communities: Burnaby, Surrey,
Tri-Cities (Coquitlam, Port Coquitlam, Port Moody), New
Westminster, Abbotsford, and White Rock. 
The MMP involves pharmacists visiting patients at home
to review medication regimens. The program focuses on 
providing clinical pharmacy services to those at high risk of
adverse drug events, such as elderly patients who have recently
been discharged from hospital with multiple medications or
others who have been identified by health care professionals as
being at high risk. Pharmacists’ activities within the MMP
include identifying and resolving drug-related issues, 
reconciling the medication regimen, providing patient educa-
tion, organizing systems to enhance medication adherence, and
removing expired, discontinued, or unused medications from
the home. Economic and clinical evaluations of the MMP have
been conducted5,6; however, humanistic outcomes such as
patient satisfaction have not been evaluated. 
Measuring patient satisfaction is an important component
of evaluating health care services. It can provide support for the
value of health care services and can also be useful in designing
and improving practice. High levels of patient satisfaction with
both clinical and dispensing pharmacy functions have been
reported in the literature.7-16 However, satisfaction with home
care pharmacy services has been sparsely reported and has been
evaluated with only small numbers of patients.7,8 Moreover, 
to the authors’ knowledge, no established, validated survey
questionnaire has been published to evaluate patient satisfac-
tion in this setting. A number of validated patient satisfaction
surveys have been developed to assess clinical pharmacy services
in outpatient settings17-20; however, these surveys contain some
items that are not relevant to the home care practice of the
MMP, and they also fail to capture some key items relevant
specifically to evaluation of satisfaction in the home care 
setting. 
The purpose of this study was to evaluate patient satisfac-
tion with the Fraser Health MMP.
METHODS
Study Population
All patients for whom a pharmacist conducted a medica-
tion review through the MMP between September 1 and
November 23, 2011, were eligible for inclusion. 
Table 1. Questionnaire Items for Evaluation of Patient Satisfaction with Medication 
Management Program, Fraser Health Authority
Item Original Tool14 As Revised for Current Satisfaction Survey
1 The pharmacist provided me with education that Unchanged
will help me achieve my goals of therapy.
2 The pharmacist helped me to understand the Unchanged
intended use (purpose) of my medication(s).
3 The pharmacist helped me to understand the Unchanged
intended results (goals of therapy) of my 
medication(s).
4 The pharmacist helped me to understand how  Unchanged
to take my medication(s) safely and correctly.
5 I feel that my overall health and well-being I feel that my overall health and well-being 
improved because of my MTM visit. improved because of the home visit I received
from the pharmacist.
6 Health care benefits should include MTM services. I would recommend this pharmacist home visit 
service continue to be available.
7 I would recommend this MTM service to my Overall, I was satisfied with the pharmacist home
family and friends. visit.
Space for respondents to provide written Open-ended questions:
comments and suggestions about the 1. Please describe up to 3 things you like most
MTM program about the pharmacist home visit program
2. Please describe up to 3 ways in which you 
would improve the pharmacist home visit 
program
MTM = medication therapy management.
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Over the past 3 years, MMP pharmacists have provided
service to, on average, 1215 patients (range 1129 to 1351) per
year. The intention was to survey consecutive patients seen over
a 2- to 3-month period to ensure that at least 10% of the total
annual patient population was captured. It was anticipated that
this approach, involving an intensive review and follow-up
period, would provide a convenience sample for the study,
while also ensuring a good survey response rate.
The majority of patients seen by the pharmacists within
the MMP are 65 years of age or older, have been recently 
discharged from hospital (within the previous 7 days), and are
taking 6 or more regularly scheduled medications at the time of
discharge. MMP pharmacists may also receive referrals from
other health care practitioners, for example, nurses, hospital
pharmacists, and physicians. 
Ethics approval for this study was provided by the Fraser
Health Research Ethics Board (approval number FHREB
2011-082).
Survey Instrument
The survey instrument developed for this study was based
on existing literature, in particular a tool developed by 
Ramalho de Oliveira and others,14 and was evaluated for face
and content validity by the MMP pharmacists. Of the 7 items
that Ramalho de Oliveira and others14 used to assess patient 
satisfaction, items 1 to 5 and item 7 were used for the current
survey instrument (numbered as items 1 through 6) either
identically or with modification to reflect the MMP home 
care setting (see Table 1). Item 7 in the current survey asked 
respondents about overall satisfaction with the MMP. Respon-
dents were asked to rate each of these 7 items on the Likert-type
scale used by Ramalho de Oliveira and others14 (1 = strongly
agree, 2 = somewhat agree, 3 = neither disagree nor agree 
[neutral], 4 = somewhat agree, and 5 = strongly agree) and to
answer 2 open-ended questions. 
Patients who received service from an MMP pharmacist
during the study period, or their caregivers, were contacted by
phone within 7 days with an invitation to participate in the
study. If they consented to participate, the survey questions
were posed over the phone. Patients or caregivers who declined
participation or who could not be reached by the interviewer
after 3 tries were categorized as nonrespondents. All surveys
were conducted by the same research assistant and took place
between September 15 and November 24, 2011. 
Data Collection
Demographic variables for the patient (age, city of residence,
and sex), as well as number of medications, number and types
of drug-related problems identified by the pharmacist, and
whether or not the patient had had a recent hospital stay, 
were collected for both respondents and nonrespondents. In
addition, the interviewer recorded whether the patient or a
caregiver responded to the survey. 
Data Analysis
Demographic data and responses to the 7 Likert-scale
items on the survey instrument were analyzed using descriptive
statistics in Microsoft Excel (Redmond, Washington). 
The demographic characteristics of the study population are 
reported as means and ranges as appropriate. Responses to
open-ended questions were evaluated by looking for common
themes. 
RESULTS
A total of 1257 individual patients received the MMP ser-
vice during 2011, the year in which this satisfaction survey was
performed; of these, 175 (13.9%) received the MMP service
during the specified study period and were invited to respond
to the satisfaction survey, and 103 (58.9%) patients or their
caregivers agreed to participate. 
The majority of the patients eligible for inclusion in this
evaluation came from Burnaby and Surrey, which together
accounted for more than half of both the respondent and 
nonrespondent groups (Table 2). On average, those who
received the MMP service had more than 3 drug-related 
problems identified by the pharmacist, and the majority of
them were seen as a result of recent discharge from hospital. 
The majority of respondents agreed or strongly agreed
with all items in the survey, including item 6, recommending
that the program continue to be available (Table 3). Among the
103 survey responses, there was only one refusal to answer a
specific question (item 5). Similarly, for most items, very few
respondents (0%–5.8%) had no opinion. The exception was
item 5, asking whether overall health and well-being had
improved as a result of the pharmacist home visit; for this 
question, 34 (33.0%) of the respondents had no opinion. The
reason given by respondents who had no opinion was that they
thought there had not been enough time to determine if their
health and well-being had improved as a result of the service. 
The first open-ended question asked respondents to
describe 3 things they liked most about the MMP, to which 76
(73.8%) of patients or caregivers responded. The primary
theme in the responses related to communication: respondents
felt that the pharmacists had been easy to understand and that
they had used everyday language rather than medical jargon,
which facilitated patients’ understanding. A second theme
related to resources provided by the pharmacists, such as a medi -
cation schedule, an action plan, and a medication information
vial for use in emergency situations (a list of the patient’s 
medications prepared by the pharmacist and placed in a medi-
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caton vial, for ready access if emergency services are required),
which were appreciated. One patient noted that seeing the
pharmacist in the home environment allowed him to feel more
at ease, because everything was more familiar and nonintrusive.
The same patient said that the MMP was good for immobile
patients and those who use wheelchairs, have difficulty 
walking, or generally have difficulty getting out of the house.
Another patient reported that she felt like she was being cared
for, rather than just another number on the ward. 
For the second open-ended question, which asked what
improvements could be made, 18 (17.5%) of patients or 
caregivers responded. The most common theme was the 
suggestion to have more pharmacist home visits. The second
most common suggestion was to offer phone visits instead of
home visits. Finally, some respondents suggested that there
should be an easier way to contact the pharmacist after the visit.
Many respondents reported that the MMP was beneficial, that
they were not expecting much to begin with, and hence that
they had no suggestions for improvement.
Table 2. Demographic and Clinical Characteristics of Study Population 
Group; No. (%)*
Characteristic Respondents (n = 103) Nonrespondents (n = 72)
Age of patient (years), mean 79.1 (65–97) 79.2 (50–94)
Sex of patient
Male 47 (45.6) 32 (44.4)
Female 56 (54.4) 40 (55.6)
Caregiver responding on behalf of patient 34 (33.0) 25 (34.7)
No. of medications, mean (range) 10.5 (4–22) 9.3 (2–9)
No. of drug-related problems, mean (range) 3.4 (0–12) 3.3 (0–9)
Recent admission to hospital 87 (84.5) 58 (80.6)
City of residence
Burnaby 34 (33.0) 19 (26.4)
New Westminster 10 (9.7) 9 (12.5)
Tri-Cities 14 (13.6) 12 (16.7)
Delta 3 (2.9) 4 (5.6)
Surrey 27 (26.2) 21 (29.2)
Abbotsford 14 (13.6) 7 (9.7)
White Rock 1 (1.0) 0 (0)
*Except where indicated otherwise.
Table 3. Results of Patient Satisfaction Survey Regarding Medication Management Program, Fraser Health
Authority
Score; No. (%) of Respondents (n = 103)
Statement Strongly Disagree Neutral Agree Strongly No Refused
Disagree Agree Opinion
1. The pharmacist provided me with 0 (0) 0 (0) 2 (1.9) 17 (16.5) 81 (78.6) 3 (2.9) 0 (0)
education that will help me achieve my 
goals of therapy.
2. The pharmacist helped me to 0 (0) 0 (0) 0 (0) 8 (7.8) 94 (91.3) 1 (1.0) 0 (0)
understand the intended use (purpose) 
of my medicines.
3. The pharmacist helped me to 0 (0) 0 (0) 3 (2.9) 15 (14.6) 79 (76.7) 6 (5.8) 0 (0)
understand the intended results (goals 
of therapy) of my medicines.
4. The pharmacist helped me to 0 (0) 0 (0) 2 (1.9) 6 (5.8) 94 (91.3) 1 (1.0) 0 (0)
understand how to take my medicines 
safely and correctly.
5. I feel that my overall health and well- 2 (1.9) 3 (2.9) 7 (6.8) 15 (14.6) 41 (39.8) 34 (33.0) 1 (1.0)
being improved because of the home
visit I received from the pharmacist.
6. I would recommend this pharmacist 1 (1.0) 0 (0) 2 (1.9) 5 (4.9) 92 (89.3) 3 (2.9) 0 (0)
home visit service continue to be available.
7. Overall, I was satisfied with the 0 (0) 0 (0) 0 (0) 5 (4.9) 98 (95.1) 0 (0) 0 (0)
pharmacist home visit.
*Except where indicated otherwise.
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in a home care setting, and the studies that have evaluated this
outcome have not clearly described the survey instrument
used.7,8 For these reasons, we chose to develop an instrument
specific to our setting. Although this instrument was based
largely on one developed to evaluate satisfaction with clinical
pharmacy services in an ambulatory setting,14 it was adapted to
make it relevant to the home care setting. Ramalho de Oliveira
and others14 reported a response rate of 28% from 1132 mailed
surveys and a high level of satisfaction among patients who
received the services and responded to the survey. Relative to
the current MMP study, the study by Ramalho de Oliveira and
others14 had a different setting for clinical pharmacy services
and included younger patients (aged 21 years and older). In
addition, those authors administered their survey by mail, after
more interaction with the pharmacist (2 visits) and over a
longer period of time (July to December 2008). Despite these
differences, most of their results were consistent with ours.
However, 95.3% of their respondents, but only 54.4% in 
our study, agreed or strongly agreed that their overall health 
and had well-being improved as a result of the pharmacist 
intervention. This difference likely relates to the fact that many
patients in the current study felt it was too soon to judge 
any improvement. 
Limitations
Although this study has provided valuable information
about patients’ experience with the MMP, there were some 
limitations. The evaluation of patient satisfaction related to
clinical services provided by the MMP pharmacists. These 
services were not provided as part of an experimental trial, 
and therefore satisfaction was not evaluated according to an
experimental design. Hence, it is unknown if receipt of this
program resulted in comparatively greater satisfaction than
would have achieved without the service or with a different 
service delivery model. The study was conducted from 
September to November, and it was assumed that the respons-
es would be the same throughout the year; however, the 
potential for seasonal variation is unknown. Also, the 
respondents were mainly from 2 of the communities in which
the MMP service was offered and may not represent all 
those who receive the service, given the potential for regional
variation.
The representativeness of the results may also have been
hampered by the sample size. Although more than 10% of
patients who received a visit from an MMP pharmacist over the
course of the year were invited to participate, the number who
responded to the survey (103) was less than 10%. Given that
the respondent and nonrespondent groups were similar in
terms of demographic and clinical information, it was assumed
that those who responded were representative of the group at
large. Another limitation is that one-third of the respondents
DISCUSSION
The results of this study indicate that respondents had a
high level of satisfaction with the MMP. These results are 
comparable to the findings of other evaluations of patient 
satisfaction with pharmacy services.7-16 They will be used to 
support the continuance of the MMP and to advocate for
expansion of the program throughout the Fraser Health
Authority. Because respondents provided few suggestions for
improvement, there was little information to guide changes to
the way in which the program is delivered. Interestingly,
although many respondents supported having this program
available, some suggested that the visits be conducted by phone
rather than in person. This indicates that for some, the level of
service offered through this program was more than was 
needed. Further work on refining the criteria for program
inclusion will be undertaken to ensure that the service is 
delivered to those for whom it is warranted.
The response rate for this study, in which the satisfaction
survey was administered over the phone (58.9%), was similar
to rates for previous similar surveys reported in the literature.
These response rates have ranged from 28% to 88.4% for mail
surveys,7,9,11,13-16,18 from 82.1% to 100% for in-person inter-
views,10,17 from 76.6% to 90.4% for self-administered surveys in
a pharmacy or clinic,19,20 and 59% for a telephone interview.8
Although patient satisfaction with pharmacy services has
been reported as high, most evaluations of satisfaction have not
used an experimental design. Among evaluations conducted by
means of comparison trials, there have been discrepancies, with
some authors reporting higher patient satisfaction among those
who received the intervention being studied than among those
who received no intervention (i.e., usual care),12,16 and other
authors reporting no difference in satisfaction between those
who received the pharmacy services intervention and those who
received usual care.21,22 In both of the studies in which patient
satisfaction with pharmacy services was higher in the interven-
tion group than the nonintervention group, the survey was
developed specifically for the evaluation and was based on 
literature and the project itself.12,16 In one of the studies in
which satisfaction was not higher in the intervention group,22
the survey used to assess patient satisfaction23 had been 
developed to assess health services in general, not pharmacy 
services in particular. In the other study that reported no com-
parative benefit of the intervention, in terms of satisfaction,21
the tool used to measure satisfaction was the General Satisfac-
tion with Pharmacy Services Scale, a satisfaction questionnaire
that has been evaluated for reliability and validity.19,24-26 The
items in this survey evaluate domains related to drug distribu-
tion and clinical services.24-26
To our knowledge, there are no validated surveys for 
evaluating satisfaction with clinical pharmacy services provided
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were family members or caregivers, rather than the patients
themselves. We have assumed that the answers given by these
representatives were the same as the patients would have given,
but this may not have been the case. 
Finally, there may have been situations in which commu-
nication was a barrier, which would limit the validity of the
results. For example, the Likert scale options may have caused
confusion, especially among those for whom English is a 
second language. The extent to which respondents had 
difficulty understanding the survey is unknown.
CONCLUSION
Overall, the results of this survey demonstrate that patients
were satisfied with the clinical pharmacy service offered
through the Fraser Health MMP. 
References 
1. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based 
intervention on unplanned readmissions and out-of-hospital deaths. J Am
Geriatr Soc. 1998;46(2):174-80.
2. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention
among patients with congestive heart failure discharged from acute hospital
care. Arch Intern Med. 1998;158(10):1067-72.
3. Naunton M, Peterson GM. Evaluation of home-based follow-up of high-
risk elderly patients discharged from hospital. J Pharm Pract Res. 2003;33(3):
176-82.
4. Jackson SL, Peterson GM, Vial JH, Jupe DML. Improving the outcomes 
of anticoagulation: an evaluation of home follow-up of warfarin initiation. 
J Intern Med. 2004;256(2):137-44.
5. Flanagan P, Virani A, Baker W, Roelants H. Pharmacists making house calls:
innovative role or overkill? Can J Hosp Pharm. 2010;63(6):412-9. 
6. Flanagan PS, Pawluk S, Bains S. Opportunities for medication-related support
after discharge from hospital. Can Pharm J. 2010;143(4):170-5.
7. Peterson GM, Fitzmaurice KD, Naunton M, Stewart K, Krum H. Impact of
pharmacist-conducted home visits on the outcomes of lipid-lowering drug
therapy. J Clin Pharm Ther. 2004;29(1):23-30.
8. MacAulay S, Saulnier L, Gould O. Provision of clinical pharmacy services in
the home to patients recently discharged from hospital: a pilot project. Can J
Hosp Pharm. 2008;61(2):103-13.
9. Zed PJ, Filiatrault L. Clinical outcomes and patient satisfaction of a pharmacist-
managed, emergency department-based outpatient treatment program for
venous thromboembolic disease. CJEM. 2008;10(1):10-7.
10. Wilkinson ST, Pal A, Couldry RJ. Impacting readmission rates and patient 
satisfaction: results of a discharge pharmacist pilot program. Hosp Pharm.
2001;46(11):876-83.
11. Collins C, Kramer A, O’Day ME, Low MB. Evaluation of patient and
provider satisfaction with a pharmacist-managed lipid clinic in a Veterans
Affairs medical center. Am J Health Syst Pharm. 2006;63(18):1723-7.
12. Community Pharmacy Medicines Management Project Evaluation Team.
The MEDMAN study: a randomized controlled trial of community 
pharmacy-led medicines management for patients with coronary heart disease.
Fam Pract 2007;24(2):189-200.
13. Holsclaw SL, Olson KL, Hornak R, Denham AM. Assessment of patient sat-
isfaction with telephone and mail interventions provided by a clinical phar-
macy cardiac risk reduction service. J Manag Care Pharm. 2005;11(5):403-9.
14. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy 
management: 10 years of experience in a large integrated health care system. 
J Manag Care Pharm. 2010;16(3):185-95.
15. Taylor J, Semchuk W, Neubauer S, Kuz G. Patient satisfaction with a 
smoking cessation program in community pharmacies. Can Pharm J. 2003;
136(5):30-4.
16. Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P;
Community Pharmacy Medicines Management Evaluation Team. Patient
evaluation of a community pharmacy medications management service. Ann
Pharmacother. 2007;41(12):1962-70.
17. Gourley GK, Gourley DR, La Monica Rigolosi E, Reed P, Solomon DK,
Washington E. Development and validation of the pharmaceutical care 
satisfaction questionnaire. Am J Manag Care. 2001;7(5):461-6.
18. Larson LN, Rovers JP, MacKeigan LD. Patient satisfaction with pharmaceutical
care: update of a validated instrument. J Am Pharm Assoc. 2002;42(1):44-50.
19. Pinto SL, Sahloff EG, Ramasamy A. Evaluating the validity and reliability of
a modified survey to assess patient satisfaction with mail-order and community
pharmacy settings. J Pharm Pract. 2010;23(2):128-34.
20. Traverso ML, Salamano M, Botta C, Colautti M, Palchik V, Pérez B. 
Questionnaire to assess patient satisfaction with pharmaceutical care in 
Spanish language. Int J Qual Health Care. 2007;19(4):217-24.
21. Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al.
A randomized trial of the effect of community pharmacist intervention on
cholesterol risk management: the Study of Cardiovascular Risk Intervention
by Pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149-55.
22. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberall H. A 
pharmacy discharge plan for hospitalized elderly patients—a randomized 
controlled trial. Age Ageing. 2001;30(1):33-40.
23. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of
client/patient satisfaction: development of a general scale. Eval Program Plann.
1979;2(3):197-207.
24. Larson LN, MacKeigan LD. Further validation of an instrument to measure
patient satisfaction with pharmacy services. J Pharm Market Manage. 1994;
8(1):125-39.
25. MacKeigan LD, Larson LN. Development and validation of an instrument to
measure patient satisfaction with pharmacy services. Med Care. 1989;
27(5):522-36.
26. Johnson JA, Coons SJ, Hays RD. The structure of satisfaction with pharmacy
services. Med Care. 1998;36(2):244-50.
Priti Flanagan, BSP, ACPR, PharmD, is Coordinator of Community
Pharmacy Programs, Fraser Health, Langley, British Columbia, and 
Clinical Assistant Professor, University of British Columbia, Vancouver,
British Columbia.
Suman Kainth, BScPharm,ACPR is a Clinical Pharmacist with 
Community Pharmacy Programs, Fraser Health, Burnaby Home Health,
Burnaby, British Columbia.
Lisa Nissen, PhD, is Professor and Head of the School of Clinical 
Sciences, Queensland University of Technology, Brisbane, Queensland,
Australia.
Competing interests: Priti Flanagan has received speakers’ fees and
payment for educational presentations on topics unrelated to this 
article from the Canadian Society of Hospital Pharmacists (CSHP), 
Pharmaceutical Services Division, and payment of travel expenses from
the CSHP Harrison Pharmacy Management Seminar. No competing
interests declared by Suman Kainth or Lisa Nissen.
Address correspondence to:
Dr Priti Flanagan
Regional Pharmacy Administration
8521 198A Street
Langley BC V2Y 0A1
e-mail: priti.flanagan@fraserhealth.ca
Acknowledgement 
The authors would like to acknowledge Christine Chow, who worked
as a research assistant on this project and was involved with the data
collection.
This single copy is for your personal, non-commercial use only.
For permission to reprint multiple copies or to order presentation-ready copies for distribution, contact CJHP at cjhpedit@cshp.ca
